NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Shares of Aurobindo Pharma gained 3.3 per cent in trade on Monday, after the company got US FDA nod for generic osteoporosis drug. The stock hit day's high of Rs 779.70 on the BSE. The pharmaceutical company said that it has received approval from the US FDA to manufacture and…

news

A new drug in early development cuts cholesterol as much as two potent injections recently cleared for sale but lasts much longer, meaning it may need to be given only every three to six months, initial findings suggest. Results with Alnylam Pharmaceuticals and Medicines Co's experimental product ALN-PCSsc highlight the…

news

Mylan NV shareholders voted Friday in favor of the company’s $35.6 billion bid for Perrigo Co., handing the generic-drug maker ammunition for an attempted hostile takeover of its rival. The bid won approval from two-thirds of votes cast at a shareholder meeting, Mylan said Friday, adding that it got support…

news

Drug manufacturer Mayne Pharma will invest $65 million at its facility in Greenville and add 110 jobs in the next five years. The Australian-based specialty pharmaceutical company develops and manufactures branded and generic products globally, in addition to providing contract development and manufacturing services. Its production portfolio includes aspirin, morphine…

news

Alvogen has entered into a definitive agreement with Pfizer Inc., under which it will acquire a portfolio of four pharmaceutical products, in the U.S. Alvogen has developed a strong track record in the U.S. market with over 60 pipeline ANDA’s, of which 28 have first-to-file or first-to-market potential. The transaction…

news

IDT Biologika announces today the acquisition of Gallant Custom Laboratories, based in Ontario, Canada. The transaction is to close August 31, 2015. Gallant Custom Laboratories is the only Canadian company authorized by the Canadian Food Inspection Agency (CFIA) to manufacture autogenous viral and bacterial vaccines. "With its strong scientific focus,…

news

As Israeli drugmaker Teva readies to acquire Allergan as part of its recent $40.5-billion deal, a large bounty of products is expected to be up for grabs for generic drugmakers. According to collated data, products worth nearly $600 million may be needed to be divested as part of the anti-trust…

news

Aurobindo Pharma has appointed Sanjeev Dani, former senior executive with Ranbaxy Laboratories, as chief operating officer and head of formulation business. The company announced the appointment on Tuesday in a call with investors while declaring its results for the first quarter of the current fiscal. Dani, who quit Ranbaxy in…

news

Harbin Gloria Pharmaceuticals Co Ltd Says plans to invest 200 million yuan ($31.19 million) in an investment fund.   reuters.com

news

Kiadis Pharma BV Reports H1 net loss of 9.6 million euros ($11.09 million) versus loss of 3.5 million euros a year ago. H1 operating loss is 11.7 million euros versus loss of 2.9 million euros a year ago. Says cash at June 30, 2015 was 2.5 million euros versus 3.6…